© 2007 European Society for Medical Oncology
epidemiology |
Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage study
1 Centre for Public Health Research, Massey University, Wellington
2 Public Health Intelligence, Ministry of Health, Wellington
3 Research Centre for M
ori Health and Development, Massey University, Wellington
4 Hepatitis Foundation of New Zealand, Whakatane, New Zealand
* Correspondence to: N. Travier, Centre for Public Health Research, Massey University, Private Bag 756, Wellington, New Zealand. Tel: +64-4-801-2794 ext. 6088; Fax: +64-4-380-0600; E-mail: n.travier{at}massey.ac.nz
Background: The purpose of this study was to examine the relationship between glycosylated hemoglobin (HbA1c) level and subsequent cancer risk.
Material and methods: HbA1c measurements were made on blood samples of participants in a hepatitis B (HB) screening program (1999–2001). Cancer incidence was determined by linkage to cancer registrations and hospitalization records to the end of 2004. Participants previously diagnosed with diabetes or cancer were excluded. Hazard ratios (HR) and 95% confidence intervals (CIs) were estimated using Cox regression.
Results: Among the 46 575 participants (70% Mori, 12% Pacific, 5% Asian and 12% Other), 634 cancer cases were observed. For all cancers combined, a significant increased risk was found in persons with moderately elevated HbA1c levels (6%–6.9%) (HR 1.40, 95% CI: 1.11–1.76), with a smaller increased risk in persons with highly elevated levels (
7%) (HR 1.09, 95% CI: 0.80–1.48) as compared with persons having low HbA1c levels (<6%). The HRs for respiratory cancers were 2.27 (95% CI: 1.34–3.86) for the moderate HbA1c category and 1.58 (95% CI: 0.77–3.26) for the upper HbA1c category. For endometrial cancers, the HRs were 4.05 (95% CI: 1.10–14.88) and 5.07 (95% CI: 1.20–21.31), respectively. For other cancer sites, no significantly increased risks were found.
Conclusions: These findings are consistent with other evidence that abnormal glucose metabolism may be associated with an increased risk of some cancers.
Key words: cancer incidence, diabetes, glycosylated hemoglobin, New Zealand
Received for publication July 12, 2006. Revision received January 17, 2007. Revision received March 16, 2007. Accepted for publication March 23, 2007.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Brewer, C. S. Wright, N. Travier, C. W. Cunningham, J. Hornell, N. Pearce, and M. Jeffreys A New Zealand Linkage Study Examining the Associations Between A1C Concentration and Mortality Diabetes Care, June 1, 2008; 31(6): 1144 - 1149. [Abstract] [Full Text] [PDF]
|
|